Molly Ferguson for STAT

STAT+ | 5 lessons from Vinay Prasad’s turbulent tenure at the FDA

Prasad, a public critic of FDA laxity, learned that being a regulator is different than being a talking head.

By Matthew Herper

STAT+ | Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales

The Danish drugmaker will drop its lawsuit, while the digital health giant will stop marketing compounded products.

By Elaine Chen

STAT+ | Talkspace to be acquired for $835 million by mental health services giant

The acquisition by Universal Health Services marks a new chapter for a digital health company that was seen as ripe to be bought by a larger firm

By Mario Aguilar

Adobe

STAT+ | As controversial decisions mount, FDA shuns public advisory meetings

Controversial drug decisions mount as FDA reduces public advisory meetings. Industry leaders say the adcomms can add transparency to the approval process.

By Lizzy Lawrence

STAT+ | Health tech company says it will dive into Medicare’s new chronic care experiment

Cadence is among the first tech companies set to participate in ACCESS model aimed at aligning payment with outcomes.

By Mario Aguilar

STAT+ | Blue Cross Blue Shield says data back up claim that AI is driving up medical bills

A new BCBS data analysis claims that AI coding tools used by hospitals are driving up medical bills, raising concerns about the affordability of health care.

By Brittany Trang

Adobe

STAT+ | After UnitedHealth moved in, Oregon sought to rein in corporate health care. Now, it’s facing an early test

PeaceHealth’s move to replace Oregon ER doctors with national staffing firm ApolloMD sparks protests and tests a new state law targeting corporate medicine.

By Tara Bannow

Opinion: The financial reason why parents beg me to diagnose their kids with autism

A behavioral/developmental pediatrician has watched autism rates rise as parents seek financial support for therapy.

By Lawrence Diller